サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1475172

低分子無菌注射剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Small Molecule Sterile Injectable Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 223 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.88円
低分子無菌注射剤の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年04月01日
発行: Value Market Research
ページ情報: 英文 223 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

低分子滅菌注射剤市場の世界需要は、2023年の1,550億5,000万米ドルから2032年には3,045億6,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは7.79%です。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、低分子無菌注射剤の世界市場における各セグメントを包括的に評価することもできます。低分子無菌注射剤業界の成長と動向は、この研究に全体的なアプローチを記載しています。

市場セグメンテーション

低分子無菌注射剤市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家は、今後の機会で、それぞれの製品やサービスの対象層を特定するのに役立ちます。

薬剤タイプ別

  • 抗生物質
  • 化学療法剤
  • 骨格筋弛緩薬
  • 麻酔薬
  • 抗凝固剤
  • 抗痙攣薬
  • 抗ウイルス剤
  • その他

製品タイプ別

  • ブランド
  • ジェネリック

投与経路別

  • 静脈内（IV）
  • 筋肉内（IM）
  • 皮下（SC）

用途別

  • 腫瘍学
  • 感染症
  • 糖尿病
  • 筋骨格系
  • 自己免疫疾患
  • 心血管疾患
  • 脳神経疾患
  • その他

流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局

地域別分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける低分子滅菌注射剤市場の現在と将来の需要を強調する地域展望を取り上げます。さらに、本レポートでは、すべての主要地域における各用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 低分子無菌注射剤-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 低分子無菌注射剤の世界市場分析：薬剤タイプ別

  • 薬剤タイプ別概要
  • 実績データと予測データ
  • 薬剤タイプ別分析
  • 抗生物質
  • 化学療法剤
  • 骨格筋弛緩薬
  • 麻酔薬
  • 抗凝固剤
  • 抗痙攣薬
  • 抗ウイルス剤
  • その他

第6章 低分子無菌注射剤の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 実績データと予測データ
  • 製品タイプ別分析
  • ブランド
  • ジェネリック

第7章 低分子無菌注射剤の世界市場分析：投与経路別

  • 概要投与経路別
  • 実績データと予測データ
  • 投与経路別分析
  • 静脈内（IV）
  • 筋肉内（IM）
  • 皮下（SC）

第8章 低分子無菌注射剤の世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • がん領域
  • 感染症
  • 糖尿病
  • 筋骨格系
  • 自己免疫疾患
  • 心血管疾患
  • 中枢神経系疾患
  • その他

第9章 低分子無菌注射剤の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 低分子無菌注射剤の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 低分子無菌注射剤企業の競合情勢

  • 低分子無菌注射剤市場競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc.
  • BioCryst Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Eisai Co. Ltd.
  • Eli Lilly And Company
  • Fresenius Kabi USA
  • Gilead Sciences Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Drug Type (USD MN)
  • Antibiotics Market Sales By Geography (USD MN)
  • Chemotherapy Agents Market Sales By Geography (USD MN)
  • Skeletal Muscle Relaxants Market Sales By Geography (USD MN)
  • Anaesthetics Market Sales By Geography (USD MN)
  • Anticoagulants Market Sales By Geography (USD MN)
  • Anticonvulsants Market Sales By Geography (USD MN)
  • Antivirals Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Product Type (USD MN)
  • Branded Market Sales By Geography (USD MN)
  • Generics Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Intravenous (IV) Market Sales By Geography (USD MN)
  • Intramuscular (IM) Market Sales By Geography (USD MN)
  • Subcutaneous (SC) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Musculoskeletal Market Sales By Geography (USD MN)
  • Autoimmune Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • CNS Disorders Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Small Molecule Sterile Injectable Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Small Molecule Sterile Injectable Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Small Molecule Sterile Injectable Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Drug Type (USD MN)
  • Antibiotics Market Sales By Geography (USD MN)
  • Chemotherapy Agents Market Sales By Geography (USD MN)
  • Skeletal Muscle Relaxants Market Sales By Geography (USD MN)
  • Anaesthetics Market Sales By Geography (USD MN)
  • Anticoagulants Market Sales By Geography (USD MN)
  • Anticonvulsants Market Sales By Geography (USD MN)
  • Antivirals Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Product Type (USD MN)
  • Branded Market Sales By Geography (USD MN)
  • Generics Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Intravenous (IV) Market Sales By Geography (USD MN)
  • Intramuscular (IM) Market Sales By Geography (USD MN)
  • Subcutaneous (SC) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Musculoskeletal Market Sales By Geography (USD MN)
  • Autoimmune Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • CNS Disorders Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114379

The global demand for Small Molecule Sterile Injectable Drugs Market is presumed to reach the market size of nearly USD 304.56 Billion by 2032 from USD 155.05 Billion in 2023 with a CAGR of 7.79% under the study period 2024 - 2032.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of small molecule sterile injectable drugs. The growth and trends of small molecule sterile injectable drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the small molecule sterile injectable drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Type

  • Antibiotics
  • Chemotherapy Agents
  • Skeletal Muscle Relaxants
  • Anaesthetics
  • Anticoagulants
  • Anticonvulsants
  • Antivirals
  • Other

By Product Type

  • Branded
  • Generics

By Route Of Administration

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)

By Application

  • Oncology
  • Infectious Diseases
  • Diabetes
  • Musculoskeletal
  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Cns Disorders
  • Other

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Small Molecule Sterile Injectable Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Small Molecule Sterile Injectable Drugs market include AbbVie Inc., Amgen Inc., AstraZeneca Plc., BioCryst Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eisai Co., Ltd., Eli Lilly and Company, Fresenius Kabi USA, Gilead Sciences, Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. SMALL MOLECULE STERILE INJECTABLE DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Drug Type
    • 3.7.2 Market Attractiveness Analysis By Product Type
    • 3.7.3 Market Attractiveness Analysis By Route of Administration
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET ANALYSIS BY DRUG TYPE

  • 5.1. Overview By Drug Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Drug Type
  • 5.4. Antibiotics Historic and Forecast Sales By Regions
  • 5.5. Chemotherapy Agents Historic and Forecast Sales By Regions
  • 5.6. Skeletal Muscle Relaxants Historic and Forecast Sales By Regions
  • 5.7. Anaesthetics Historic and Forecast Sales By Regions
  • 5.8. Anticoagulants Historic and Forecast Sales By Regions
  • 5.9. Anticonvulsants Historic and Forecast Sales By Regions
  • 5.10. Antivirals Historic and Forecast Sales By Regions
  • 5.11. Other Historic and Forecast Sales By Regions

6. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1. Overview By Product Type
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Product Type
  • 6.4. Branded Historic and Forecast Sales By Regions
  • 6.5. Generics Historic and Forecast Sales By Regions

7. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1. Overview By Route of Administration
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Route of Administration
  • 7.4. Intravenous (IV) Historic and Forecast Sales By Regions
  • 7.5. Intramuscular (IM) Historic and Forecast Sales By Regions
  • 7.6. Subcutaneous (SC) Historic and Forecast Sales By Regions

8. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET ANALYSIS BY APPLICATION

  • 8.1. Overview By Application
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Application
  • 8.4. Oncology Historic and Forecast Sales By Regions
  • 8.5. Infectious Diseases Historic and Forecast Sales By Regions
  • 8.6. Diabetes Historic and Forecast Sales By Regions
  • 8.7. Musculoskeletal Historic and Forecast Sales By Regions
  • 8.8. Autoimmune Disorders Historic and Forecast Sales By Regions
  • 8.9. Cardiovascular Diseases Historic and Forecast Sales By Regions
  • 8.10. CNS Disorders Historic and Forecast Sales By Regions
  • 8.11. Other Historic and Forecast Sales By Regions

9. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By Distribution Channel
  • 9.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 9.5. Retail Pharmacies Historic and Forecast Sales By Regions
  • 9.6. Online Pharmacies Historic and Forecast Sales By Regions

10. GLOBAL SMALL MOLECULE STERILE INJECTABLE DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE SMALL MOLECULE STERILE INJECTABLE DRUGS COMPANIES

  • 11.1. Small Molecule Sterile Injectable Drugs Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF SMALL MOLECULE STERILE INJECTABLE DRUGS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. AbbVie Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Amgen Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. AstraZeneca Plc.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. BioCryst Pharmaceuticals Inc.
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Bristol-Myers Squibb Company
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Eisai Co. Ltd.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Eli Lilly And Company
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Fresenius Kabi USA
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Gilead Sciences Inc.
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Merck KGaA
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Novartis AG
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Pfizer Inc.
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments
  • 12.15. Sanofi
    • 12.15.1 Company Overview
    • 12.15.2 Company Revenue
    • 12.15.3 Products
    • 12.15.4 Recent Developments
  • 12.16. Sun Pharmaceutical Industries Ltd.
    • 12.16.1 Company Overview
    • 12.16.2 Company Revenue
    • 12.16.3 Products
    • 12.16.4 Recent Developments
  • 12.17. Teva Pharmaceutical Industries Ltd.
    • 12.17.1 Company Overview
    • 12.17.2 Company Revenue
    • 12.17.3 Products
    • 12.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies